Bipolar Disorder Linked to Increased Risk for Major Adverse Cardiac Events
A team of researchers investigated the relationship between bipolar disorder and major adverse cardiac events.
A team of researchers investigated the relationship between bipolar disorder and major adverse cardiac events.
Investigators examined healthcare costs of adult patients with mild, moderate, moderately severe, and severe major depressive disorder and compare them with a control group representative of the general population.
Researchers conducted web-based focus groups to better understand patient preferences for medication management of a serious mental illness.
A team of investigators sought to assess the efficacy of brexpiprazole as an adjunct to antidepressant treatment in patients with major depressive disorder and anxious distress.
Investigators sought to assess the effect of zuranolone vs placebo on the sexual functioning of adults with major depressive disorder.
Researchers conducted an 8-week, open-label, single-arm study and a subsequent 2-stage, sequential, parallel comparison study to assess the use of pimavanserin among patients with Parkinson disease and major depressive disorder.
Researchers conducted a study to evaluate the validity of, and satisfaction with, the Cognition KIT DSST mobile app in patients with major depressive disorder.
Investigators conducted a comprehensive literature search to identify key characteristics that best differentiate between bipolar I disorder and major depressive disorder.
The approval was based on the ASPIRE I and II trials that compared the efficacy and safety of esketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist, to placebo in 449 adults with moderate to severe MDD who had active suicidal ideation and intent.
Investigators sought to determine the prevalence of psychotic features in patients with major depressive disorder.